Retrospective chart review on psychiatric manifestations of GLP-1 agonist usage

CONCLUSIONS: GLP-1 RAs appear psychiatrically well-tolerated for most patients, though new-onset or worsening symptoms occur in a minority, underscoring the need for monitoring, particularly in high-risk populations. Prospective studies are warranted to clarify causality, mechanisms, and potential therapeutic roles in psychiatric care.

via https://pubmed.ncbi.nlm.nih.gov/41616750/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1HYeX0emtvYgH07Wkz0a8n9otrdMd-JIklc_uo0I5vh1u9WMEy&fc=None&ff=20260201010807&v=2.18.0.post22+67771e2